Novai Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Series A
  • (In Progress)

  • Latest Deal Amount
  • $806K

  • Investors
  • 16

Novai General Information

Description

Developer of retinal imaging technology designed to enable early detection and management of eye and brain diseases. The company offers a proprietary biologic combined with advanced image analysis to provide real-time, single-cell insights into retinal cell stress and death, enabling healthcare providers to predict disease activity earlier and improve patient outcomes.

Contact Information

Website
www.novai.co.uk
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9 Greyfriars Road
  • Berkshire
  • Reading RG1 1NU
  • England, United Kingdom
+44 020
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Digital Health, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 9 Greyfriars Road
  • Berkshire
  • Reading RG1 1NU
  • England, United Kingdom
+44 020

Novai Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novai Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Later Stage VC (Series A) $806K In Progress Clinical Trials - General
15. Later Stage VC 27-Apr-2026 Completed Generating Revenue
14. Early Stage VC 18-Dec-2024 Completed Clinical Trials - General
13. Accelerator/Incubator 01-Jan-2024 Completed Clinical Trials - General
12. Accelerator/Incubator Completed Clinical Trials - General
11. Accelerator/Incubator Completed Clinical Trials - General
10. Early Stage VC (Series A) 31-Aug-2023 Completed Clinical Trials - General
9. Grant 01-Jul-2022 Completed Clinical Trials - General
8. Seed Round 22-Nov-2021 $2.48M $4.64M Completed Clinical Trials - General
7. Seed Round 31-Mar-2021 $1.35M $2.16M Completed Clinical Trials - General
To view Novai’s complete valuation and funding history, request access »

Novai Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary A
Ordinary A
Ordinary A
Ordinary A
Ordinary A
Ordinary A
Ordinary A 56,254 $0.000013 $23.16 $23.16 1x $23.16 8.42%
Ordinary A 41,667 $0.000013 $16.08 $16.08 1x $16.08 6.24%
To view Novai’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Novai Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of retinal imaging technology designed to enable early detection and management of eye and brain diseases. The
Other Pharmaceuticals and Biotechnology
Reading, United Kingdom
15 As of 2026

Vienna, Austria
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novai Competitors (3)

One of Novai’s 3 competitors is RetInSight, a Corporate Backed or Acquired company based in Vienna, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RetInSight Corporate Backed or Acquired Vienna, Austria
Cascader Venture Capital-Backed London, United Kingdom
Eyenuk Venture Capital-Backed San Francisco, CA
You’re viewing 3 of 3 competitors. Get the full list »

Novai Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 7

    Pending

  • Expiring in next 12 mo

Novai Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026234039-A1 Marker for use in identifying or predicting diseases of the macula Pending 05-May-2025
AU-2021392993-A1 Marker for use in identifying or predicting angiogenesis Pending 03-Dec-2020
AU-2021392993-A9 Marker for use in identifying or predicting angiogenesis Pending 03-Dec-2020
CA-3200936-A1 Marker for use in identifying or predicting angiogenesis Pending 03-Dec-2020
EP-4255505-A1 Marker for use in identifying or predicting angiogenesis Pending 03-Dec-2020 A61K49/0056
To view Novai’s complete patent history, request access »

Novai Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novai Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Wealth Club Corporation Minority
Female Foundry Accelerator/Incubator
Active Capital (London) Venture Capital Minority
Telarik Venture Capital Minority
The FSE Group Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial

Novai FAQs

  • When was Novai founded?

    Novai was founded in 2020.

  • Where is Novai headquartered?

    Novai is headquartered in Reading, United Kingdom.

  • What is the size of Novai?

    Novai has 15 total employees.

  • What industry is Novai in?

    Novai’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Novai a private or public company?

    Novai is a Private company.

  • What is Novai’s current revenue?

    The current revenue for Novai is .

  • How much funding has Novai raised over time?

    Novai has raised $10M.

  • Who are Novai’s investors?

    Wealth Club, Female Foundry, Active Capital (London), Telarik, and The FSE Group are 5 of 16 investors who have invested in Novai.

  • Who are Novai’s competitors?

    RetInSight, Cascader, and Eyenuk are competitors of Novai.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process